COMBINED EFFECT OF OBETICHOLIC ACID AND BEZAFIBRATE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADEQUATE RESPONSE TO OR INTOLERANCE OF URSODEOXYCHOLIC ACID: RESULTS FROM TWO PHASE 2 CLINICAL TRIALS

被引：0
|
作者：
Levy, Cynthia [1 ]
Hejda, Vaclav [2 ]
Louvet, Alexandre [3 ]
Younes, Ziad [4 ]
Mendizabal, Manuel [5 ]
Bonder, Alan [6 ]
Zou, Heng [7 ]
Civitarese, Antonio [7 ]
Villamil, Alejandra [8 ]
Nevens, Frederik [9 ]
机构：
[1] Univ Miami, Sch Med, Coral Gables, FL 33124 USA
[2] Univ Hosp Plzen, Plzen, Czech Republic
[3] Univ Hosp Lille, Lille, France
[4] Gastro One, Germantown, TN USA
[5] Hosp Univ Austral, Pilar, Argentina
[6] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[7] Intercept Pharmaceut Inc, Morristown, NJ USA
[8] Hosp Italiano Buenos Aires, Hepat Autoimmun Unit, Buenos Aires, DF, Argentina
[9] Univ Hosp KU Leuven, Leuven, Belgium
来源：
HEPATOLOGY | 2024年 / 79卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
5019-C
引用
收藏
页码：E52 / E52
页数：1
相关论文
共 50 条
  • [41] Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes
    Cheung, A. C.
    Lapointe-Shaw, L.
    Kowgier, M.
    Meza-Cardona, J.
    Hirschfield, G. M.
    Janssen, H. L. A.
    Feld, J. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (02) : 283 - 293
  • [42] BEZAFIBRATE TREATMENT FOR PATIENTS WITH PRIMARY BILIARY CIRRHOSIS WHO HAVE AN INCOMPLETE RESPONSE TO URSODEOXYCHOLIC ACID THERAPY
    Hazzan, R.
    Tur-Kaspa, R.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S244 - S245
  • [43] IMPACT OF COMBINATION THERAPY WITH URSODEOXYCHOLIC ACID AND BEZAFIBRATE ON PATIENT OUTCOMES IN PRIMARY BILIARY CHOLANGITIS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Khakoo, Nidah S.
    Sultan, Shahnaz
    Serna, Myrna K.
    Bhamidimarri, Kalyan R.
    Levy, Cynthia
    GASTROENTEROLOGY, 2020, 158 (06) : S1374 - S1375
  • [44] A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)
    Corpechot, C.
    Chazouilleres, O.
    Rousseau, A.
    Guyader, D.
    Habersetzer, F.
    Mathurin, P.
    Goria, O.
    Potier, P.
    Minello, A.
    Silvain, C.
    Abergel, A.
    Debette-Gratien, M.
    Larrey, D.
    Roux, O.
    Bronowicki, J. -P.
    Boursier, J.
    De Ledhingen, V.
    Heurgue-Berlot, A.
    Nguyen-Khac, E.
    Zoulim, F.
    Ollivier-Hourmand, I.
    Zarski, J. -P.
    Nkontchou, G.
    Gaouar, F.
    Simon, T.
    Poupon, R.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S89 - S89
  • [45] Alteration of Gut Microbiota in Primary Biliary Cholangitis Patients with Non-Response to Ursodeoxycholic Acid
    Lin, Qiu-Xiang
    Lin, Fei
    Gan, Qiao-Rong
    Wang, Xue-Wen
    Huang, Zu-Xiong
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2022, 36 (04): : 1137 - 1145
  • [46] Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA
    Li, Jia
    Lu, Mei
    Zhou, Yueren
    Bowlus, Christopher L.
    Lindor, Keith
    Rodriguez-Watson, Carla
    Romanelli, Robert J.
    Haller, Irina, V
    Anderson, Heather
    VanWormer, Jeffrey J.
    Boscarino, Joseph A.
    Schmidt, Mark A.
    Daida, Yihe G.
    Sahota, Amandeep
    Vincent, Jennifer
    Wu, Kuan-Han Hank
    Trudeau, Sheri
    Rupp, Loralee B.
    Melkonian, Christina
    Gordon, Stuart C.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (08) : 4170 - 4180
  • [47] MORTALITY RISK OF PATIENTS WITH HEPATIC DECOMPENSATION FROM PRIMARY BILIARY CHOLANGITIS IN THE OBETICHOLIC ACID ERA
    Mannalithara, Ajitha
    Kim, W. Ray
    Sripongpun, Pimsiri
    Kwong, Allison J.
    Goel, Aparna
    HEPATOLOGY, 2019, 70 : 783A - 783A
  • [48] A randomized, controlled trial on fenofibrate in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid
    Li, Chunlei
    Zheng, Kunyu
    Chen, Yiran
    He, Chengmei
    Liu, Suying
    Yang, Yunjiao
    Li, Mengtao
    Zeng, Xiaofeng
    Wang, Li
    Zhang, Fengchun
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2022, 13
  • [49] Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA
    Jia Li
    Mei Lu
    Yueren Zhou
    Christopher L. Bowlus
    Keith Lindor
    Carla Rodriguez-Watson
    Robert J. Romanelli
    Irina V. Haller
    Heather Anderson
    Jeffrey J. VanWormer
    Joseph A. Boscarino
    Mark A. Schmidt
    Yihe G. Daida
    Amandeep Sahota
    Jennifer Vincent
    Kuan-Han Hank Wu
    Sheri Trudeau
    Loralee B. Rupp
    Christina Melkonian
    Stuart C. Gordon
    Digestive Diseases and Sciences, 2022, 67 : 4170 - 4180
  • [50] A phase 2 proof of concept study of MBX-8025 in patients with Primary Biliary Cholangitis (PBC) who are inadequate responders to ursodeoxycholic acid (UDCA)
    Jones, David
    Galambos, Michael R.
    Swain, Mark G.
    Doerffel, Yvonne
    Steinberg, Alexandra
    Varga, Monika
    Choi, Yun-Jung
    Martin, Robert
    McWherter, Charles
    Chera, Harinder
    Boudes, Pol
    Hirschfield, Gideon M.
    HEPATOLOGY, 2016, 64 (06) : 1123A - 1124A
12345